Tuesday, 29 October 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $AUSA.C) (OTC: $EPAZ) (OTCQB: $SING) (CSE: $CRFT.C) (TSX: $FAF.TO)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE:
$AUSA.C) (OTC: $EPAZ) (OTCQB: $SING) (CSE: $CRFT.C) (TSX: $FAF.TO)
Delta, Kelowna, BC –October 29, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/10291AUSA-EPAZ-SING-CRFT-FAF.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In
today’s podcast we look at a few early announcements.
But
first, Hempcorp recently secured a 10,000 acre site set to become the
world's largest hemp plantation. This comes following the legalisation of hemp
cultivation within the state of Uttarakhand, India.
The company will be managing operations in
Uttarakhand and has plans for a variety-based product chain from hemp. The
product chain will vary from health foods, cosmetics, textiles, FMCGs,
pharmaceuticals, cannabis-infused ayurvedic medicines, eco-friendly
construction materials, bioplastics, biofuel and more. Hemp-based paper,
plastics and fuel will foster a more sustainable future.
The company has been engaging with
government officials and liaisons regarding regulatory compliance. A recent
industry development was made by the government in licensing cannabis
cultivation, processing and refinement for the production of ayurvedic
medicines containing CBD and THC content.
The company has made the recent decision to
proactively participate in the formation of a cannabis society for the
decriminalisation, legalisation and advocacy of cannabis in India. Further, is
in partnership discussions with technologists regarding bleeding edge
technologies in cannabinoid extraction.
Hempcorp expects the market to grow at an
exponential rate over the next 3 years into a multi-billion-dollar industry and
is seeing a growing interest in foreign investment into India's cannabis space.
Given these factors, the company is also focusing on the creation of an Indian
hemp market.
Australis Capital
Inc. (CSE: AUSA) (OTC: AUSAF) announced the formation of Cocoon Technology LLC, a
cloud-based, self-service fulfillment platform and wholly-owned subsidiary of
AUSA. Designed to enhance the consumer experience and reduce labor costs,
Cocoon delivers operational efficiency to dispensaries while improving order
fulfillment, cash management, bankcard acceptance, data analytics, customer
loyalty, marketing, privacy, and compliance. Cocoon's Platform-as-a-Service
model delivers contracted recurring revenue, one-time revenue, exclusive
multi-year agreements, enhanced product offerings and an extensive runway of
future innovations.
With
the launch of CocoonPod®, Cocoon unites state-of-the-art self-service kiosks
with mobile applications, platform agnostic integrations into leading
enterprise resource planning (ERP)/business management systems, and payment
providers. CocoonPod® features consumer-facing kiosks as stand-alone units or
multi-unit pods as the core consumer point-of-interaction (POI), coupled with a
consumer mobile application and tablet for employee assisted self-service transactions,
providing a full omni-commerce solution for brick-and-mortar locations.
"The
benefits of deploying self-service technology have been demonstrated across all
brick-and-mortar retail sectors in the United States and AUSA's management
experience and leadership in self-service technology positions AUSA for
immediate success across North America," states Michael Carlotti, Chief
Financial Officer of AUSA. "The estimated market opportunity for kiosk
sales to dispensaries in the United States over the next five years is 50,000
units with a recurring revenue model based on a percentage of sales initiated
within CocoonPod®. Cocoon has met with leading Multi-State Operators (MSO) and
focus groups with conservative assumptions suggesting 60-80% of returning
customers will choose to initiate their purchase through a self-service
POI."
CocoonPod®
functionality delivers reduced transaction times, privacy, coin-less cash
recycling, payment gateway, ATM processing, ID validation, QR codes, consumer
loyalty, charitable donations, and numerous marketing opportunities through a
dynamic user interface. By integrating Coil®, a loyalty and data application
built by AUSA's wholly-owned subsidiary Rthm Technologies ("Rthm"),
CocoonPod® also offers fully integrated loyalty functionality for consumers,
now branded as CocoonRewards®.
"Since
being acquired by AUSA the Rthm team has created the industry's most powerful
data-driven mobile loyalty application which will integrate directly within the
CocoonPod® platform providing operators and consumers a user experience and
point-of-purchase options never before available," states Alex Mosa,
President of Rthm. "We are excited to release this impactful product into
the U.S. market."
CocoonPod®
self-service kiosks and integrated form factors were developed in partnership
with Passport Technology Inc. ("Passport"), the International
award-winning technology provider to brick-and-mortar casinos and hospitality.
With over a decade of experience developing robust, intuitive, aesthetically
pleasing self-service kiosk technology, payment applications, loyalty rewards,
compliance programs, and opt-out optionality to highly regulated and high
traffic industries, Passport's reputation of developing and supporting these
technologies is unparalleled.
"As
the industry continues to expand, retailers seek opportunities to streamline
operations and enhance consumer experiences. CocoonPod® is the future for
highly regulated brick-and-mortar environments where privacy, Know Your
Customer (KYC), Anti-Money Laundering (AML), and social responsibility are
critical," states Kurt Sullivan, President of Passport. "Our
partnership with Cocoon will immediately address known pain points while
introducing new functionality for all stakeholders within the dispensary and
retail eco-system."
Epazz, Inc. (OTC: EPAZ), a leading provider of drone technology,
blockchain mobile apps and cloud-based business software solutions, has announced that its holdings ZenaPay, Inc. has signed
five beta customer agreements in order to commercialize its drone smart farming
solution. The ZenaPay team in August 2019 beta tested its drone mapping and
plant tracking solutions in Ireland on two farms. The beta test was a success,
signing up additional beta customers. The company has been updating the
software and developing its own drone technology based on the feedback from the
Ireland trip.
Epazz,
Inc., which formed Farm Drone, Inc. earlier this year, will license exclusively
its drone technology to ZenaPay, Inc. The drone will be called ZenaDrone 1000.
It will be the first generation drone we develop for the Agriculture industry.
ZenaDrone 1000 will be a workhorse for farms, which will have multiple
functions and features to scan fields and remove the male hemp plant in order
to double female hemp production. The feedback we received from our trip to
Ireland has provided us an opportunity to extend our technology to include
tracking livestock and testing soil samples.
Epazz
will be maintaining its twitter page with updates about the drone development
and the company on a daily basis. You can visit our twitter page at https://www.twitter.com/epazz
Dr.
Shaun Passley, CEO of Epazz & ZenaPay, said, “We believe that Artificial
Intelligence (“AI”) and our facial recognition technology are the next
technologies to positively impact agriculture production. Our agreements with 5 beta customers will
demonstrate the benefits of the ZenaPay Drone Farm Software; and the efficiency
gained from tracking plant growth from seed to harvest.”
SinglePoint, Inc. (OTCQB: SING) has launched into the smokable hemp market. Their newly
released brand 1606 Original Hemp is gaining traction after much attention at
the 2019 National Association of Convenience Stores launch. The company
received orders on site at the show and gathered over 100 interested clients
that collectively own over 15,000 locations. SinglePoint expects to make its
first large sale in the near future and has shipped orders to a collective 250
locations.
Pure
American Hemp cigarettes are nicotine and tobacco free. Some research suggests
that smoking hemp cigarettes could be a potential tool to replace tobacco and
nicotine addictions. According to a Brightfield Group survey of more than 5,000
CBD users in the U.S.:
● 24% have used it to help quit smoking.
● Quitters are often replacing cigarettes
with either smokable hemp or vaping.
with either smokable hemp or vaping.
● 41% of quitters have entirely replaced
tobacco with hemp CBD.
tobacco with hemp CBD.
Google
trends reveals over the last year that hemp was researched more often than
tobacco and nicotine.
The
Alternative Market has continued to grow by 35%, from 2019 to 2018 while
cigarettes stayed steady at 3.1%. With the addition of hemp cigarettes and the
recent vape scare, many assume the alternative market will continue growing as
people look for a “healthier for you” alternative to cigarettes.
Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary HifyreTM
Inc., announced the successful launch of the Spark PerksTM
cannabis members program across the Fire & Flower retail network.
Members
of the Spark Perks program receive exclusive benefits including: Fastlane
checkout, special deals, member-only events and exclusive content. Spark Perks
is free to join and no cannabis purchase is required to join the program.
Since
the program's official launch on September 19, 2019, Spark Perks has grown to
more than 38,000 members. Of those members, 33% have conducted a second
transaction since the creation of the member profile. Initial results indicate
that on average, Spark Perks members spend 43% more than non-members, per
transaction, in the Fire & Flower retail network.
"Since
the launch of the Spark Perks program, Fire & Flower has seen an increase
in customer engagement and basket size of members across our retail
network," shared Trevor Fencott, Chief Executive Officer of Fire &
Flower. "The launch of the Spark Perks member program demonstrates Fire
& Flower's continued commitment to be a leading data-driven, 'retail 2.0'
company."
"Hifyre
has been developing Spark Perks for more than six months and we are delighted
to see positive initial results in the member program," shared Matthew
Hollingshead, President of Hifyre. "Hifyre continues to be at the
forefront of digital cannabis retail. We focus on developing secure, data
driven retail tools that connect customers with the brands and products they
love."
Pasha Brands Ltd. (CSE: CRFT) (OTC: CRFTF) commented on the legal retail market in Canada and
what separates them from the competition.
Between
2014 and 2018 global sales of legal cannabis more than tripled from $3.4
billion to $10.9 billion, according to the State of the Legal Cannabis Markets
report from Arcview Market Research. BDS Analytics calls for a near-quadrupling
from 2018 levels to $40.6 billion by 2024 at an annual growth rate of 21.9%.
This has led many people to wonder, why the recent market downturn in the
cannabis sector?
"Legal
cannabis, particularly in Canada, has been struggling under the weight of
burdensome regulations, poor supply-chain management, and quality issues,"
said Jamie Shaw, Chief Communications and Culture Officer for Pasha.
"Coupled with that, companies in the sector were slow to deliver the
results expected and were generally seen as overvalued. Share prices were
determined at a time when there were relatively few licences that seemed to
have a stranglehold on the regulated marketplace."
While
these challenges are most pronounced in today's market, for Pasha it has been
an affirmation of its business plan. "We never bought into the big-box
mentality that's causing many of these problems," Shaw said. "Pasha
has focused on small batch, craft producers, and has been meeting its goals at
a quick pace, with the first micro-cultivation harvest expected in December."
Pasha
has been on-boarding brands and people that made legalization possible,
including Baked Edibles, Earth Dragon Organics, and Beard Brothers Collective,
and has acquired a Health Canada licensed facility on Vancouver Island. Pasha
expects to be the first licensed, nation-wide, all-craft company to be
operational by end of Q4 2019/early Q1 2020.
Of
the first 5 micro-licences issued by Health Canada, Pasha has signed supply
agreements with all of them. Pasha also has signed supply agreements with 60
more applicants currently in the CTLS queue with Health Canada, and another 40
navigating the licensing process with Pasha subsidiary, BC Craft Supply Co.
Ltd. With 100 micro-cultivators each permitted to produce up to 500kg per year,
Pasha could have the ability to bring up to 50,000kg per year of high-quality
craft cannabis to Canadian consumers.
"The
legal market has yet to see products with the same care and attention to detail
that went into the highest quality, illicit products," said Patrick Brauckmann,
Executive Chair of Pasha Brands. "Pasha is committed to bringing products
to the marketplace that put the consumer first."
Partnered
with powerful distributors like Great North and developing innovative industry
solutions like Craft Labs, Pasha looks to disrupt how people think of legal
cannabis.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas Investorideas.com is a recognized news source
publishing third party news, research and original financial content. Learn
about investing in stocks and sector trends with our news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech and
Climate Change , Exploring Mining
the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure : (OTCQB: SING) is a paid annual
news and social media company on Investorideas.com More disclaimer
info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
SinglePoint Inc. (OTCQB: $SING): #Hemp Cigarettes - What You Need to Know About One of the Fastest Growing Segments of Hemp; @_Singlepoint_
SinglePoint Inc. (OTCQB: $SING):
#Hemp Cigarettes - What You Need to Know About One of the Fastest Growing
Segments of Hemp; @_Singlepoint_
PHOENIX - October 29, 2019 (Investorideas.com
Newswire) SinglePoint, Inc. (OTCQB:SING) has launched into the smokable hemp market. Newly released brand 1606
Original Hemp is gaining traction after much attention at the 2019 National
Association of Convenience Stores launch. The company received orders on site
at the show and gathered over 100 interested clients that collectively own over
15,000 locations. SinglePoint expects to make its first large sale in the near
future and has shipped orders to a collective 250 locations.
Hemp has been globally cultivated for thousands of
years, but what is hemp and what makes the plant so special? Hemp is a strain
that comes from the Cannabis Sativa plant species, it is an agricultural crop
grown for seed and fiber. "Some of
the earliest known uses of hemp began in China about 10,000 BCE, where it was
used for making clothing, rope, and paper."
In today's world, hemp is becoming very popular.
The use of hemp has evolved into diverse products such as lotions, oils, food,
beverages, and cigarettes. Smokable hemp is a developing trend, but is it a
good way to consume the cannabinoid? Here's what you need to know:
Hemp vs. Marijuana
Hemp and marijuana are both part of the cannabis
family. However, hemp will not get you high unlike marijuana, which is known
for its psychoactive effects. Marijuana has high levels of
THC, containing anywhere from 5%-35% whereas hemp has less than 0.3% THC. Hemp contains high cannabidiol (CBD) content which is not
psychoactive. Smoking hemp is a positive alternative to marijuana, "You get
the same taste, the same psychological feeling of smoking a joint, but without
the high."
Replacing Tobacco
Pure American Hemp cigarettes (link) are nicotine
and tobacco free. Some research suggests that smoking hemp cigarettes could be
a potential tool to replace tobacco and nicotine addictions. According to a
Brightfield Group survey of more than 5,000 CBD users in the U.S.:
·
24% have used it to help quit smoking.
·
Quitters are often replacing cigarettes
·
with either smokable hemp or vaping.
·
41% of quitters have entirely replaced
·
tobacco with hemp CBD.
Google trends reveals over the last year that hemp
was researched more often than tobacco and nicotine.
Initial Research
Initial research has shown CBDs ability to reduce
cigarette consumption. Researchers at University College London conducted a study of 24 smokers. Each were given an inhaler with
CBD or placebo. For one week they were to use the inhaler when they had the
urge to smoke. Those with placebo had no difference in cigarettes smoked, those
with the CBD inhaler significantly reduced the number of cigarettes smoked by
40%.
The Alternative Market
The Alternative Market has continued to grow
drastically, 35%, from 2019 to 2018 while cigarettes stayed steady at 3.1%.
With the addition of hemp cigarettes and the recent vape scare, many assume the
alternative market will continue growing as people look for a "healthier
for you" alternative to cigarettes.
The Future
BDS Analytics and Arcview Market Research projects
that the collective market for CBD sales in the U.S. will surpass $20 billion
by 2024 while New York-based investment bank Cowen & Co, estimates that the
market could pull in $15 billion by 2025. The smokable hemp market currently
represents approximately 2% of the overall CBD market, but with a 250% growth
from 2017 to 2018, Brightfield Group, a Chicago-based cannabis market research
firm, identifies dried and smokable hemp flowers as one of the fastest-growing
segments of the CBD market.
About SinglePoint, Inc.
SinglePoint, Inc (SING) is a technology and
investment company with a focus on acquiring companies that will benefit from
the injection of growth capital and technology integration. The company
portfolio includes mobile payments, ancillary cannabis services and blockchain
solutions. Through acquisitions into horizontal markets, SinglePoint is
building its portfolio by acquiring an interest in undervalued companies,
thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products
and services to the cannabis industry.
Connect on social media at:
Forward-Looking Statements
Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under the Securities
Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are
subject to the safe harbor created by those rules. All statements, other than
statements of fact, included in this release, including, without limitation,
statements regarding potential future plans and objectives of the Company, are
forward-looking statements that involve risks and uncertainties. There can be
no assurance that such statements will prove to be accurate and actual results and
future events could differ materially from those anticipated in such
statements.
Technical complications, which may arise, could
prevent the prompt implementation of any strategically significant plan(s)
outlined above. The Company undertakes no duty to revise or update any
forward-looking statements to reflect events or circumstances after the date of
this release.
Corporate Communication
SinglePoint Inc.
855-711-2009
investors@SinglePoint.com
SinglePoint.com
855-711-2009
investors@SinglePoint.com
SinglePoint.com
More info on SING at Investorideas.com Visit: https://www.investorideas.com/CO/SING/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced
news, articles and equity research as well as creates original content,
including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. For Disclosure purposes
SinglePoint Inc (OTCQB: SING) is a paid annual news and social media
company on Investorideas.com. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp and https://www.investorideas.com/About/News/Clientspecifics.asp . Learn more about our prices for publishing your
news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone
the use of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Get more Cannabis
Stock Investor Ideas - news, articles, podcasts and stock
directories
Hot #Cannabis #Stocks - It’s Always Sunny in #Israel; (CSE: $IPOT) (TSXV: $KHRN.V) (TSX: $AVCN.TO) (TSXV: $PCLO.V)
Hot #Cannabis
#Stocks - It’s Always Sunny in #Israel; (CSE: $IPOT) (TSXV: $KHRN.V) (TSX:
$AVCN.TO)
(TSXV: $PCLO.V)
Snapshot Looking at Cannabis Global
Expansion from Israel to the EU
Point
Roberts WA, Delta, BC – October 29, 2019 - Investorideas.com, a
leading investor news resource covering cannabis and hemp stocks releases a
sector snapshot reporting on the continued international expansion of the
cannabis industry and how it’s leading to a global cannabis infrastructure.
Read this in full
at https://www.investorideas.com/news/2019/cannabis/10291Israel.asp
A
recent article reporting
on the growth of the global cannabis industry notes, “Fully 185 countries are
signatories to the United Nations’ Single Convention on Narcotic Drugs of 1961,
which prohibits cannabis as a drug that can be abused and cause ill effects,
without bringing a substantial therapeutic advantage. Each signatory’s laws
must reflect the Convention; that is the case for the US’ Controlled Substances
Act of 1971. Countries that have legalized cannabis are flouting the
convention, and some, such as Canada, admit that openly.”
“Thanks to changing
public perceptions, moves such as Canada’s, ongoing research on health benefits
and risks, and the urging of the World Health Organization—in 2019 it came out
in favor of less restrictive control of cannabis and of removing prohibitions
for pure CBD and CBD preparations containing no more than .2% THC—the United
Nations has said it will revisit cannabis under the Single Convention. It
should be noted, however, that amending the convention is difficult with so
many members involved.”
“Medical
use of cannabis is and will be accepted around the world a lot more quickly
than recreational use,” says Mario
Torres of Brazeau Seller Law
(Ottawa, Ontario, Canada). “People are not enthused about prohibiting medical
care. They don’t want to disallow access to the only thing that may stop
epileptic seizures in children or is part of a patient’s treatment plan.”
Medical use is becoming more acceptable even in very conservative countries
like South Korea and Thailand, which have legalized cannabis for medical
purposes.
Recent
news headlines look to
Israel saying,” Israel is at the forefront of cannabis tech. The country, which
produces more pharmaceutical cannabis than just about anywhere else, is poised
to become a leading exporter.”
Recently
listed on the CSE,
Isracann Biosciences Inc. (CSE:
IPOT) is an Israeli-based cannabis company focused on
becoming a premier cannabis producer offering low-cost production targeting
undersupplied, major European marketplaces. The Company (formerly Atlas
Blockchain Group Inc.), recently provided an operative overview and update
regarding facility development activities in Israel.
Concurrent
to and as part of the Company’s recent listing on the Canadian Securities
Exchange it had satisfied the escrow release conditions for the net proceeds of
its highly successful CAD$10.1 million financing efforts which bolstered an
already healthy cash position.
This
positions the company to immediately accelerate its planned Phase One Facility
Design and Construction Services Program which consists of finalization of
greenhouse facility design for cannabis cultivation and production in
accordance with an existing technical specifications strategy; to rapidly
advance greenhouse and related facility construction per the design; ensure
adequate controls are in place against any diversion, theft and loss of
cannabis products per regulatory standards; and ensure compliance with other
protective security, health, and safety requirements in accordance with Israeli
regulations.
To
date, Isracann has entered into agreements for the development of medical cannabis
cultivation projects with regional stakeholders holding preliminary breeding
and cultivation licenses issued by the Israeli Ministry of Health. The regional
stakeholder is required to renew these licenses each year and further bears the
cost of electricity, property and related land taxes and are bound to working
with Isracann to obtain the required licenses and to participate in the
construction of the greenhouses.
Isracann
‘s CEO, Darryl Jones notes, “We are very pleased to have achieved our very important
initial milestone targets with the CSE listing of our ticker symbol “IPOT” and
to confirm our accelerated investment plans in Israel are fully underway. We
have lined up several key organizations and personnel and look forward to
announcing a number of these key commercial agreements in the days and weeks
ahead. We thank all our supporters for their belief in us, and in our belief
that the Israeli agricultural sector will provide a huge leading role in
positioning the Isracann brand as market leaders in the massive and underserved
European cannabis marketplace.”
In
related news, the Company welcomes the recent appointment of Irit Arbel, Ph.D.
to its Board of Directors. Dr. Arbel brings significant senior
multidisciplinary biopharma and governance experience to Isracann’s board. She
serves as CEO, Co-Founder and Director of Neurocords Ltd., a company focused on
developing new treatments for peripheral and spinal cord regeneration, and
previously served as Director and President of Brainstorm Cell Therapeutics,
and as Executive Vice President of Research and Development at Savicell
Diagnostic, a biotechnology company. Dr. Arbel previously served as Chairperson
of Real Aesthetics, a company specializing in cellulite ultrasound treatment,
and BRH Medical, a developer of medical devices for wound healing. She was also
Director of M&A at RFB Investment House, a private investment firm focusing
on early-stage technology-related companies. Previously, Dr. Arbel was
President and Chief Executive Officer of Pluristem Life Systems, a
biotechnology company, and prior to that as Israeli Sales Manager of Merck,
Sharp & Dohme, a pharmaceutical company. Dr. Arbel earned her Ph.D. in 1997
in Neurobiology, after performing research in the area of MS. Dr. Arbel also
holds a Chemical Engineering degree from the Technion, Israel’s Institute of
Technology.
Avicanna Inc.(TSX:
AVCN) (OTCQX:
AVCNF), a biopharmaceutical company focused on the
development, manufacturing and commercialization of cannabinoid-based products,
recently
announced that Santa Marta Golden Hemp S.A.S., its majority
owned subsidiary, has completed commercial exports of its Aureus™ brand of
CBD-based products to South Africa and the United Kingdom.
The
Aureus brand of products include an organic and sustainable line of
plant-derived active pharmaceutical ingredients ("APIs") and bulk CBD
formulations developed by Avicanna in collaboration with SMGH and Sativa Nativa
S.A.S. ("Sativa Nativa"), which is also a majority owned subsidiary
of Avicanna. These initial sales included the export of CBD isolate and 4% bulk
formulation for CBD oil sublingual sprays. Each of the above exports has been
completed in accordance with all applicable laws in the Jurisdictions.
Aras
Azadian, Avicanna's Chief Executive Officer, stated "We are excited to
bring the Aureus brand of cannabinoid APIs to our international customers. We
believe these initial sales further validate the brand's opportunities in these
two countries, as well as the potential for us to actively market our APIs
across the globe to manufacturers of CBD products. We believe the Aureus brand
of API products will become a leader in organic and sustainable cannabinoid raw
materials and the gold standard with respect to global quality controls, which
we believe are necessary for the evolution of a worldwide cannabinoid industry.”
Avicanna
is also looking into the Latin American market having announced the
retail launch of its Pura Earth™ derma-cosmetics line of CBD products, which
are now available at approximately 59 high-end retail locations throughout
Colombia, including Blind Prestige beauty shops and Cromantic professional
beauty markets.
Khiron Life
Sciences Corp. (TSXV:
KHRN) (OTC:
KHRNF), a vertically integrated cannabis leader with core
operations in Latin America, recently
announced their entrance into the EU market having completed the
EU cosmetic regulatory process for seven Kuida products, and received a
"no objection" letter from TSXV with respect to distribution of these
products in the UK.
Tejinder
Virk, President, Khiron Europe, commented, "The fulfillment of EU cosmetic
regulatory requirements allows the Company to bring our proven product line
into the sophisticated and growing European skincare market, where we expect to
rapidly build and grow Kuida's market share. We will initially focus on import
and marketing in UK, with our first sales expected in Q1 2020, before expanding
to Spain, Germany and the broader European market, subject to the specific
requirements of individual member states and TSXV approval."
Kuida®,
the first consumer brand of Khiron's wellness business unit, brings the
benefits of cannabidiol (CBD) to a comprehensive portfolio of skin and body
care products for women. Kuida was launched in Colombia in October 2018 through
retail, wholesale and online channels and is now available nationwide and
through e-commerce channels. As the Company expands Kuida® distribution in
Europe, the brand will be a featured exhibitor at Cosmoprof Worldwide Bologna
2020, which attracted over 265,000 visitors in 2019 and is the largest such
event to learn more about market leading products and to place orders.
The
company also participated
in
the Open Parliament held by Senate of Mexico on the theme of "Towards
Cannabis Regulation," which took place through August 2019 and September
2019. As a Latin American cannabis leader with a strong presence in Mexico,
Khiron joined both open forum sessions and a committee of experts to engage in
dialogue and provide input on the building blocks of the country's new
regulatory framework.
PharmaCielo Ltd. (TSXV:PCLO) (OTC:
PHCEF), whose anticipated acquisition of Australian
Securities Exchange ("ASX") listed Creso Pharma will establish a
global medicinal cannabis company positioned to rapidly develop new markets and
grow sales in the expanded footprint served by the combined company, recently announced key
developments in respect of its acquisition originally announced on June 6,
2019. Creso Pharma has informed the Company that it has received approval from
the Supreme Court of Western Australia to convene meetings of its shareholders
and listed option holders, and if thought fit, to approve the Schemes of
Arrangement whereby PharmaCielo would acquire all of the issued and outstanding
shares and listed options of Creso Pharma. The Meetings will be held on
November 11, 2019, beginning at 10:00AM (Perth time).
The
Board of Directors of Creso Pharma continue to unanimously recommend that Creso
Pharma Shareholders and the Creso Pharma Optionholders vote in favour of the
proposed Schemes of Arrangement, in the absence of a superior proposal for
Creso Pharma.
David
Attard, CEO of PharmaCielo commented, "PharmaCielo's acquisition of Creso
Pharma, creates a combined company that has operational excellence across the
value chain. The quality and scale of PharmaCielo's cultivation and extraction
compliments Creso Pharma's product development and extensive developed global
sales channels. With the Creso Pharma acquisition and our recently announced agreement to export CBD into the United States , 2020
is going to be an exciting year for PharmaCielo shareholders."
PharmaCielo
expects that the combined company will be well-positioned to drive significant
value for both existing PharmaCielo and Creso Pharma shareholders.
PharmaCielo
has received conditional approval from the TSX Venture Exchange for the
issuance of common shares of PharmaCielo to Creso Pharma Shareholders and Creso
Pharma Optionholders in order to effect the Schemes of Arrangement. The
effective date of the Schemes of Arrangement is expected to be November 13,
2019; and the closing date of the acquisition is expected to be November 22,
2019.
With
the growing international acceptance of the cannabis industry, companies with
strongly established infrastructure in key global trade areas will become more
of an essential asset as the industry moves further towards global standards
and sales.
About Investorideas.com - News that
Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining,
sports biotech, water, renewable energy and more. Investor Idea’s original
branded content includes the following podcasts and columns : Crypto
Corner , Play by Play
sports and stock news column, Investor
Ideas Potcasts Cannabis
News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining, the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
Disclosure: this news article featuring CSE: IPOT is a paid for news release on
Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Get more Cannabis Stock
Investor Ideas - news, articles, podcasts and stock
directories
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T...